论文部分内容阅读
近年来,肝动脉碘油药物栓塞化疗(Lp-TAE)已发展成为中晚期肝癌的主要治疗方法之一。我科从1993年2月～1995年2月对39例中晚期难切除的原发性肝癌行Lp-TAE术,近期疗效较为满意,现特报告如下。 材料和方法 本文共39例,男性31例,女性8例。年龄20～65岁,平均43岁。全部病例术前均经CT(或MR),肝动脉造影及血AFP检查临床确诊,其中3例获肝细胞癌的病理诊断。单结节型4例、多结节型11例、巨块型18例,弥漫型6例。直径7～30cm,平均16.5cm。AFP阳性(400～40000ug/1)33例,阴性6例。
In recent years, hepatic artery lipiodol embolization chemotherapy (Lp-TAE) has developed into one of the main treatments for advanced liver cancer. From February 1993 to February 1995, our department performed Lp-TAE on 39 cases of primary hepatocarcinoma that were difficult to be removed in the middle and late stages. The short-term curative effect was relatively satisfactory. The special report is as follows. Materials and Methods A total of 39 cases were included in this study, 31 were male and 8 were female. Age from 20 to 65 years old, an average of 43 years old. All cases were diagnosed by CT (or MR), hepatic arteriography, and blood AFP before surgery. Three of them were diagnosed as pathological diagnosis of hepatocellular carcinoma. There were 4 cases of single nodular type, 11 cases of multinodular type, 18 cases of massive type, and 6 cases of diffuse type. Diameter 7 ~ 30cm, an average of 16.5cm. AFP was positive (400-40000ug/1) in 33 cases and negative in 6 cases.